Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
about
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular DiseasesThe renal channelopathiesA novel therapeutic effect of statins on nephrogenic diabetes insipidusProtein trafficking defects in inherited kidney diseasesNephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuriaAcute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney.High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentrationWNK4 is the major WNK positively regulating NCC in the mouse kidneyAdenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.Aberrant glycosylation and localization of polycystin-1 cause polycystic kidney in an AQP11 knockout model.Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivoRegulation of transport in the connecting tubule and cortical collecting ductGeneration and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene.Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.Mouse models and the urinary concentrating mechanism in the new millennium.Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.Dissecting the roles of aquaporins in renal pathophysiology using transgenic mice.Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus.Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.Cell culture models and animal models for studying the patho-physiological role of renal aquaporins.Congenital nephrogenic diabetes insipidus: the current state of affairs.Urinary concentration: different ways to open and close the tap.Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.FAPP2 is required for aquaporin-2 apical sorting at trans-Golgi network in polarized MDCK cells.Function of the membrane water channel aquaporin-5 in the salivary glandKLHL3 Knockout Mice Reveal the Physiological Role of KLHL3 and the Pathophysiology of Pseudohypoaldosteronism Type II Caused by Mutant KLHL3.Pancreas-specific aquaporin 12 null mice showed increased susceptibility to caerulein-induced acute pancreatitis.Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.Aquaporin Protein-Protein Interactions.Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.Dominant-negative suppression of big brain ion channel activity by mutation of a conserved glutamate in the first transmembrane domain.Plant and Mammal Aquaporins: Same but Different.Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus.Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.Generation and analyses of R8L barttin knockin mouseProgranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus
P2860
Q26768170-2F8A4530-7EC5-4F81-90FD-5D0B120C30F1Q26824023-EBD46640-4BD6-4417-B06D-1736379EC230Q27005638-0FFB1981-2291-49E0-860A-87B28B7229D6Q27012909-07FAD8FB-332D-41EC-9088-C86AF4965EE0Q33639484-28377792-2D11-4153-91A2-CBF336A0CDF0Q33872558-3E55BDF2-C467-417E-AE17-D4C8B762B003Q34016466-436B3C5C-DF31-4254-8429-461881E2B5E8Q34295359-A2CF76A3-DD0E-4DEA-A706-A36172DBAE4FQ34420520-B8F0FEC1-229D-47F7-864F-80C5AEF19117Q34457128-75650F47-1047-4871-89F6-F9BAFDB9DEFBQ34568735-D7E5303E-021C-4AE3-9167-C8BB19D0638AQ35452558-31C5F329-9D77-46DC-A436-941B6F634931Q36425591-5D2E4F32-6947-41D9-A973-8C08DF967178Q36450027-C94DD7B6-AAED-4207-898C-76A9F8D1A33AQ36506665-C3BA93DF-0526-4CF8-BE7D-7479EE82C196Q36724058-241503CE-3A28-4206-8D3D-5BD9DF7DBDCCQ36967665-8BDE8E1D-2E59-4BD8-8202-BED8A4B69FEEQ37072437-57B2B1D8-D97B-4651-9933-F621CE3EB25AQ37145917-A5455904-7A21-40DE-87F2-CF4ABA67042EQ37179668-C3038BDD-873B-49C4-9580-852DF82F9CA0Q37268479-0FA21DC9-CB02-498E-805A-A7AF22CABE29Q37363078-7CAA3146-7E2E-4C67-A66F-87E219329376Q37609062-7A94E3CF-3FF0-4263-BC7E-B9691BAC64B9Q37970634-D9B3AAE8-4A52-4E2A-B236-204D96A360D3Q37994652-97A21C6F-67F3-43F1-ACE5-B5915BCD0B22Q38111968-04187996-5C83-4316-87D7-139E18615414Q38152961-18691B0D-F571-4008-92A0-98D60D1C9D61Q39793118-8A429118-2626-444C-B3D6-7E0A496E4DD2Q41192332-7E8AE1BA-F266-4AFC-98A1-6D409EBE92E3Q41728387-2C5A853F-34E6-44CF-B681-313F9C76BC82Q43281809-E64D4944-84C6-425B-AFD3-61A9822A62CAQ46146557-8B9FE0B7-886D-4DFD-8205-8467AE7AD0C2Q47108955-5EE9D6C1-3C91-4279-A5EB-BB91B7D7EECFQ47802729-F67CA86E-95CE-42E8-A273-47DAAA69E77FQ48785426-7D6F790A-9960-4F70-A3AA-D5EA63DD3DDDQ50117395-BA7669AD-0F9F-41B1-9A00-42E64E568EF1Q52686527-07592F07-05C1-4776-AB52-9D476C0C3C8DQ53051338-63B2AD70-BF19-4ABF-A6B9-8E745CD2B274Q56974878-C738D6A8-6CA1-49C2-A220-11D8FFB9EEDCQ57051332-3C7D248C-D586-46F0-AE00-6D7EBAC0A2E7
P2860
Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@ast
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@en
type
label
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@ast
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@en
prefLabel
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@ast
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@en
P2093
P2860
P356
P1476
Pathogenesis and treatment of ...... ed by an aquaporin 2 mutation.
@en
P2093
Akihiro Harada
Eisei Sohara
Keiko Uchida
Kosaku Nitta
Mayuko Ohno
Sei Sasaki
Shigeru Horita
Shinichi Uchida
Sung-Sen Yang
Tatemitsu Rai
P2860
P304
14217-14222
P356
10.1073/PNAS.0602331103
P407
P577
2006-09-12T00:00:00Z